CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...